We describe a system for monitoring and controlling i.v. anaesthesia in rats using burst suppression ratio (BSR) detection in the extradural EEG. After bolus injection, peak BSR values of 95% were achieved with propofol 8 mg kg produced a peak BSR of 70% (larger doses were not tolerated). Recovery was fastest with propofol, followed by etomidate and alphaxalone with equal duration, and slowest with thiopental. In further experiments, a closed-loop infusion system maintained BSR accurately at targets of 30%, 50%, 70% or 90% for 60 min with propofol or etomidate. During these experiments the infusion rates were found to decrease with time, more so with etomidate (approximately 40%) than with propofol (approximately 20%). Recovery times were 2-3 times longer with etomidate than with propofol. This model demonstrated differences between i.v. anaesthetics and may be useful in screening new compounds in preclinical development. (Br.
Improved understanding of the pharmacokinetics and pharmacodynamics of i.v. anaesthetics during the past decade has facilitated their widespread use. These advances are illustrated in the clinical use of target-controlled infusion (TCI) systems based on population variables 1 but also in articles addressing clinical predictors such as context-sensitive half-time, relevant effect-site decrement time and mean effect time.
2-4 Development of new i.v. anaesthetics should build on knowledge of current drugs and determine key characteristics at an early stage. One such characteristic is the tendency to accumulation with prolonged infusion and consequent delay in recovery.
Glen anaesthetized mice with propofol 5 and, when they recovered, administered the same dose again and repeated this process through multiple cycles. Recovery times after these repeated injections were similar. In contrast, with thiopental, accumulation led to rapidly increasing recovery times. Thus simple experiments with small animals may provide useful discrimination between i.v. anaesthetics. However, such repeated dose experiments do not achieve steady state nor do they indicate if stable anaesthesia can be maintained.
In closed-loop systems for drug delivery, the effect of a drug is measured and used to adapt the rate of infusion to approach target-effect values. Closedloop systems have been described in animals, 6 in patients 7 8 and in simulation 9 studies. In principle the feedback in these systems may account for sources of variability in the processes between drug delivery and drug response, of which the most obvious is the inaccuracy of population pharmacokinetic models as applied to individuals in open loop TCI systems. For use during early phases of drug discovery, a pharmacokinetic model is not yet available. In this investigation we evaluated the use of a closed-loop system with i.v. anaesthetics in the absence of a pharmacokinetic model to determine if such a system might, in the future, provide useful new information on new drugs.
For this purpose, an adaptive, integrative and proportional feedback module is described to maintain a constant EEG effect during 60-min infusion periods with propofol and etomidate.
Before designing a closed-loop system, a reliable measure of drug effect is required. Intermittent cortical activity known as burst suppression (BS) in the human electroencephalogram (EEG) has been noted since 1936, occurring after large doses of barbiturates and some volatile anaesthetics. 10 Quantitative animal data on BS are sparse, with the exception of threshold methods, where drugs are titrated to induce BS periods of 0.5 s or longer. 11 12 BS patterns induced by isoflurane and enflurane in the pig, 13 and by propofol and isoflurane in rabbits 14 have been studied, and differences in BS states induced by different hypnotics in rats have been emphasized. 15 Thus BS appears to be a general phenomenon occurring with many different classes of anaesthetic drugs. Rampil and Laster 16 introduced computerized BS extraction with isoflurane in the rat, where a time continuous BS measure on a graded scale expressed the percentage of time where the EEG was quiescent. We have adapted and optimized this technique to i.v. anaesthetics in the rat and used the EEG variable for feedback in a closed-loop system.
Materials and methods
Studies were performed at Organon Laboratories in the Netherlands in accordance with Dutch animal welfare regulations. Male Wistar rats, weighing 220-300 g, were maintained in a 12-h light-dark cycle (lights on at 13:00), housed individually, and allowed free access to food and water. Experiments were performed between 09:00 and 13:00. For this study, 41 animals were used: 17 received bolus injections, 24 received closed-loop infusions. Some animals in the bolus group were used repetitively, with a minimum of 1 week between injections.
EEG ELECTRODES: SURGICAL PROCEDURE Rats were instrumented with chronically implanted extradural electrodes. Briefly, rats weighing approximately 200 g were anaesthetized with pentobarbital 60 mg kg 91 i.p. and placed in a stereotactic frame. The skull was exposed and four small stainless steel electrodes (diameter 0.6 mm) were positioned through the skull with their tips just touching the dura mater at stereotactic co-ordinates: (electrode 1) A (anterior) 6 (mm) L (lateral) 3 (mm), (electrode 2) A6L-3, (electrode 3) A0L0 and (electrode 4) A10L2 relative to the lambda. The electrodes were wired to a small connector, fixed with dental cement and the skin was closed, leaving access only to the upper part of the connector. Buprenorphine 0.05 mg kg 91 s.c. was administered for postoperative analgesia and the rats were returned to their cages for at least 1 week before the start of an experiment.
EEG RECORDING
A shielded cable led from the connector on the rat's head to custom-built amplifiers. Two symmetrical potential differences were recorded, between electrodes 1 and 3, and between electrodes 2 and 3, respectively. Electrode 4 was used as the ground electrode. EEG was amplified 5100 times, filtered (93 dB@0.16 Hz; 6 dB oct 91 to 93 dB@200 Hz; 12 dB oct
91
) and digitized at 641.03 Hz with 12-bit resolution (1:4096, corresponding to 0.479:1961 V) by a signal processor (Cambridge Electronic Design, model 1401, Cambridge, UK) interfaced to a PC running MS-DOS.
BOLUS INJECTION
Injections were made with a computer-controlled laboratory infusion pump (Harvard Apparatus, model 44, Edenbridge, UK) into a tail vein, with 25-gauge needles connected with 250 mm of Teflon tubing (inner diameter 0.56 mm) to 1-ml syringes. Duration of drug injection was 10 s and injection volume was 0.2-0.4 ml. Rats were restrained gently by hand between needle insertion and loss of righting (typically 30 s). EEG recording commenced at the start of the bolus injection, after having verified that baseline EEG was normal and artefact-free by visual inspection on the PC screen.
CONTINUOUS INFUSION
One to two hours before the experiments the rat was instrumented with a tail vein catheter (Braunule, Braun, 22G). For infusion, this catheter was connected with 250 mm of Teflon tubing (inner diameter 0.56 mm) to 2.5-ml syringes. Infusion pump, restraining of animals and start of EEG recording were identical to the bolus injection protocol. 16 is temporal differentiation. This step enhances higher frequency components while attenuating lower frequency components in the EEG signal, eliminating slow baseline drifts and delta activity while amplifying transient bursting activity. This greatly enhances the sensitivity of BSR extraction. Time differentiation was performed digitally by taking the differences between each two successive samples in the digitized EEG. The definition of BSR sets the upper limit of BS detection (BSR:100%) equal to a 15-s period without bursts, which only occurs after high doses of general anaesthetics.
Maximum sensitivity of BS detection was guaranteed by the following procedure: from 5 min of baseline EEG of six untreated rats (30 min of EEG in total), recorded during pilot experiments preceding the experiments for this study, a search algorithm repeatedly determined BSR, starting with 100 V for the voltage threshold and 100 ms for the minimum allowed BS duration. The threshold value was decreased gradually until no single epoch of BS was detected in this baseline EEG, which occurred at 15 V. BSR extraction with the selected variable values was tested extensively in pilot experiments and found to compare well with visual detection of BS epochs. The intermediate steps in BSR extraction are illustrated in figure 1 .
Both recorded EEG channels were processed, resulting in two BSR values. Results and rats were discarded if large systematic differences (915%) indicated asymmetry in the electrode implantation. Any BSR reported in this article is the average of two single channel BSR values. The algorithm is implemented in Pascal (Microsoft) and combined with EEG monitoring routines, infusion pump drivers and a user interface into integrated programs running on a PC.
CLOSED-LOOP SYSTEM

Induction of anaesthesia
At the start of an experiment, anaesthesia was induced with a loading dose injected at a rate of Iind for 30 s. Iind was chosen to deliver in 30 s the dose which was predicted to produce the appropriate BSR in the bolus experiments. The infusion rate was then reduced to 0.2 Iind until 60 s when the closed-loop system took over. Rats were restrained gently by hand until loss of righting. Although the specific value for Iind determined the speed of induction of anaesthesia and the initial accuracy of approaching the BSR target, an inappropriate value would readily be corrected by the closed-loop system.
Maintenance of anaesthesia
The feedback algorithm was in effect from 1-60 min after the start of drug infusion. Briefly, the discrete, constant flow of BSR (one value per second) was presented at the input of a signal processing algorithm. The output of this algorithm controlled the infusion pump. The algorithm essentially increased the infusion rate if the actual BSR was smaller than the pre-set BS target and vice versa, while at the same time it adapted the set-point of this proportional system according to a rough estimate of the time characteristics of the drug being tested. The system is fully characterized by two equations, the first describing adaptation of the system on a relatively long time scale of several minutes, the second describing the instantaneous corrections (each second) of drug infusion.
Moving average filter
At each time step j, equal to 1 s, a weighted average of the infusion rate signal I during the past N seconds is calculated as:
M is thus the convolution of I and D. D:drug-specific part of the feedback model and can optimally be derived from an accurate pharmacokinetic-pharmacodynamic analysis for the individual being tested. As we wished to develop this system in a drug development setting, such a model is assumed not to be known for these experiments and a population mean estimate is used instead: the function D is filled with the averaged BSR response measured after bolus injection in a group of animals, and normalized such that the sum of all N non-zero coefficients of D (the area under the curve of the function D) is equal to 1 to convert it to a weighting function.
M determines the set-point of the feedback system at each instant of time: it represents the anticipated infusion rate that, given the recent history of infusion rates and the known time response of the drug, maintains BSR at its target value. If, at the start of an experiment, Ij9i refers to an infusion rate before the closed-loop mode is in effect (j-i:60), the initially selected maintenance rate at 0.2 Iind is used instead.
Determining new infusion rate
For optimal performance, corrections to deviations from the BSR target need to be made as early as possible. To achieve this, at each time step a new actual infusion rate value is calculated from the current BSR (Bj) and the anticipated infusion rate set-point (Mj) as:
where S controls the amplification of the feedback loop and T is the BSR target.
Stimulus-response measurement
To obtain an indication of the degree of reflex suppression during steady state anaesthesia, a mild pressure stimulus (140 g mm 
Results
BOLUS INJECTIONS
The four drugs were tested at multiple doses (on average four) on four animals per dose. BS patterns induced by the four drugs were consistent and reproducible. With all drugs tested, BS started to develop at a dose only slightly higher than needed to induce loss of righting reflex. The maximum BSR and persistence of BS increased with increasing dose. , respectively. These doses were found to be the lowest to produce a peak BSR larger than 90% in all four rats per group, except for thiopental, where doses larger than 32 mg kg 91 resulted in excessively long recovery times and respiratory depression. The four drugs yielded different shaped BSR curves. Propofol and thiopental showed a faster initial decay in BSR than alphaxalone and etomidate. BSR persisted longer after thiopental compared with the other agents. With propofol, BSR returned fastest to baseline. The times to regain righting reflex, as indicated by the arrows, corresponded with BSR approaching zero.
CONTINUOUS INFUSIONS
The drug-specific moving average functions D in equation (1) In pilot experiments we found that values for S in the range 3-7 performed well and S was fixed at a value of 5. During the first 10 min after the start of an experiment, there were marked fluctuations in BSR and infusion rate. During this phase the system was adapting to the response to the initial bolus infusion, which often had an undershoot or overshoot depending on the drug sensitivity of the animal being tested. As an example, figure 4 shows the first 5 min of a propofol closed-loop infusion experiment, where the BSR target T was 70% and the induction rate Iind was 18 mg kg 91 min 91 (corresponding to an induction dose of 9 mg kg 91 over 30 s). After the initial predetermined infusions during the first minute, the BSR target was not reached, and the system responded immediately by increasing the infusion rate to correct this. When the BSR target was reached, a slight overshoot occurred at approximately 2 min. During this overshoot the closed-loop system started to force BSR back to its target by reducing the infusion rate. At 5 min BSR was only slightly above its target.
Typically, within 10 min BSR stabilized around its target. Closed-loop infusion experiments with propofol and etomidate at BSR targets of 30%, 50%, 70% and 90% are shown in figure 5 . Each curve represents the mean of three animals. The induction rates for 30%, 50%, 70% and 90% BSR targets were 14, 16, 18 and 22 mg kg 91 min 91 for propofol, and 5, 6, 7 and 9 mg kg 91 min 91 for etomidate. The closed-loop system stabilized BSR at all targets, as can be seen from the BSR traces in figure 5 . Performance was also assessed quantitatively in each individual experiment. For this purpose the standard deviation (SD) of the BSR distribution around the BSR target during the 10-50-min time interval (2400 s) was determined according to equation (3) . The first 10 min were excluded because of the initial fluctuations, and the last 10 min because in some experiments the paw pressure stimulus influenced BSR stability. For etomidate, mean infusion rates during the 10-60-min interval to maintain 30%, 50%, 70% or . The infusion rates to maintain steady BSR decreased with time for both drugs. Figure 6 illustrates this decrease over successive 10-min intervals.
With etomidate, the infusion rate decreased until the end of the infusion and declined to approximately 60% of its initial value during the last 10 min. With propofol, an almost constant infusion rate at 80% of its starting value was reached after 40 min. Figure 7 shows recovery times after the end of infusions. With higher BSR targets, both the time to halving of BSR and the time to regain the righting reflex increased steeply. After closed-loop infusions at 90% BSR, recovery was much slower than after bolus injections that produced high BSR values (990%, see fig. 2 ).
The paw withdrawal response was not suppressed (normal) at the 30% BSR target with both drugs in all rats. In the traces at this target in figure 5 , a response in the BSR signals to this stimulus can be observed as a transient trough coinciding with a peak in the infusion rate. At 50%, paw withdrawal was weak with propofol and moderate to normal with etomidate, and still present in all animals. At 70% the response with etomidate was weak in two and absent in one of three animals, and absent with propofol in all three animals. At 90% none of the animals responded to either drug.
Discussion
Compared with published definitions of burst suppression detection, our method has improved sensitivity, extending the dynamic range to lower anaesthetic levels. This is demonstrated by the fact that doses well within the advised dosing ranges for i.v. induction of general anaesthesia in rats (e.g. thiopental 30 mg kg 91 , alphaxalone 6-9 mg kg 91 18 ) produced clearly detectable, drug-characteristic BS responses. Elementary variables of a drug, such as speed of induction of anaesthesia or potency, could be derived from these BSR responses. Their values could be calibrated on traces whereby a maximum specified BSR effect is reached, enabling accurate comparisons between drugs.
Our closed-loop infusion system performed well in maintaining BSR at multiple stable targets with etomidate and propofol. The selected cortical effect (BSR) was reached within the first minutes of the infusion and was maintained accurately until 60 min. Paw stimulation, although intended to measure reflex suppression, also demonstrated the ability of the system to cope with sudden changes in BSR caused by arousal reactions. The system responded well with appropriate alterations in infusion rate and rapidly corrected anaesthesia back to its target.
As our system requires no input values other than those derived easily from bolus injection experiments, it is well suited to test new i.v. anaesthetic compounds of which the pharmacokinetics and pharmacodynamics are unknown. Appropriate testing of a new i.v. anaesthetic would first determine if it can be used for maintaining anaesthesia at specified levels for a prolonged period, and would estimate the required doses. Recovery times after these maintained infusions could be determined and compared with those after bolus injections. Large increases, an order of magnitude larger than seen with propofol or etomidate shown here, would indicate serious, unacceptable accumulation and dominating redistribution of the drug. [2] [3] [4] During stable anaesthesia, established using a closed-loop system, other measures to assess depth of anaesthesia could be tested and cardiorespiratory and other variables could be measured easily. We found that paw withdrawal during propofol anaesthesia was less pronounced than the response during etomidate anaesthesia. This illustrates that at a cortically (EEG) defined level of anaesthesia, suppression of other responses may vary between drugs.
Finally, the system could be used to obtain the pharmacokinetic-dynamic characteristics of a drug. Some important kinetic characteristics of the drug are represented in the infusion rate against time curve, 17 and in the recovery profiles after infusions. 2 If plasma sampling is included, full and flexible pharmacokinetic-pharmacodynamic modelling is feasible. The design and use of a closed-loop system to render a pharmacokinetic-pharmacodynamic model is the opposite of the traditional approach, where a pharmacokinetic-pharmacodynamic model, known in detail, is incorporated into the design of an open-or closed-loop infusion system. 7 8 Our system shows that even without detailed information on a drug, excellent closed-loop performance can be achieved. We tested our system with two "short-acting" i.v. anaesthetics which are used clinically for maintenance of anaesthesia in humans. Etomidate and propofol equilibrate moderately fast with the effect site, and both are well described by Figure 5 Performance of the closed-loop system over 60 min. Animals were anaesthetized with propofol (left) and etomidate (right) at four different burst suppression targets of 30% (top), 50%, 70% and 90% (bottom). The lower, thick traces are the drug infusion rates and the upper, thin traces the burst suppression ratio (BSR) responses during and after the 60-min infusion period. All traces represent the mean of three animals. For clarity, data from the first 2 min after induction are omitted. Note a transient decrease in BSR as a response to the paw withdrawal measurement at the 50th minute at the 30% target with both drugs.
three-compartmental models with a relatively fast and dominating first distribution phase. 19 The question arises if our system can also maintain a steady effect with drugs that have either a slower onset or a less favourable distribution-elimination profile. The purpose of the system however is to assist in the selection of new drugs to be used as clinical anaesthetics and one might argue that drugs with inadequate responses should be discarded.
In summary, we have built a closed-loop system for maintenance of stable i.v. anaesthesia in rats and we propose that this apparatus could expedite the appropriate selection and rejection of candidate compounds in an anaesthetic drug development programme. The characteristics of propofol and etomidate might serve as standards in this selection process. 
